null

SMILES: CCC(C1CC1)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](C)O)c1

InChI Key: InChIKey=LZEQHKULKROZGJ-KTQQKIMGSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 455552   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Non-receptor tyrosine-protein kinase TYK2 (Homo sapiens (Human))	BDBM455552 ((S)-1-(4-(4-(1-((R)-1-cyclopropylpropyl)-1H-pyrazo...) Show SMILES CCC(C1CC1)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](C)O)c1 |r| Show InChI InChI=1S/C21H25N7O/c1-3-19(15-4-5-15)27-12-17(9-24-27)21-20-6-7-22-28(20)13-18(25-21)16-8-23-26(11-16)10-14(2)29/h6-9,11-15,19,29H,3-5,10H2,1-2H3/t14-,19?/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc.; Celgene Corporation US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10730880 (2020) BindingDB Entry DOI: 10.7270/Q2CC13R9
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK1 (Homo sapiens (Human))	BDBM455552 ((S)-1-(4-(4-(1-((R)-1-cyclopropylpropyl)-1H-pyrazo...) Show SMILES CCC(C1CC1)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](C)O)c1 |r| Show InChI InChI=1S/C21H25N7O/c1-3-19(15-4-5-15)27-12-17(9-24-27)21-20-6-7-22-28(20)13-18(25-21)16-8-23-26(11-16)10-14(2)29/h6-9,11-15,19,29H,3-5,10H2,1-2H3/t14-,19?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	550	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc.; Celgene Corporation US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10730880 (2020) BindingDB Entry DOI: 10.7270/Q2CC13R9
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM455552 ((S)-1-(4-(4-(1-((R)-1-cyclopropylpropyl)-1H-pyrazo...) Show SMILES CCC(C1CC1)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](C)O)c1 |r| Show InChI InChI=1S/C21H25N7O/c1-3-19(15-4-5-15)27-12-17(9-24-27)21-20-6-7-22-28(20)13-18(25-21)16-8-23-26(11-16)10-14(2)29/h6-9,11-15,19,29H,3-5,10H2,1-2H3/t14-,19?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc.; Celgene Corporation US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10730880 (2020) BindingDB Entry DOI: 10.7270/Q2CC13R9
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK3 (Homo sapiens (Human))	BDBM455552 ((S)-1-(4-(4-(1-((R)-1-cyclopropylpropyl)-1H-pyrazo...) Show SMILES CCC(C1CC1)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](C)O)c1 |r| Show InChI InChI=1S/C21H25N7O/c1-3-19(15-4-5-15)27-12-17(9-24-27)21-20-6-7-22-28(20)13-18(25-21)16-8-23-26(11-16)10-14(2)29/h6-9,11-15,19,29H,3-5,10H2,1-2H3/t14-,19?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
ARRAY BIOPHARMA INC.; CELGENE CORPORATION US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US11028093 (2021) BindingDB Entry DOI: 10.7270/Q2T156RN
					More data for this Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2 (Homo sapiens (Human))	BDBM455552 ((S)-1-(4-(4-(1-((R)-1-cyclopropylpropyl)-1H-pyrazo...) Show SMILES CCC(C1CC1)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](C)O)c1 |r| Show InChI InChI=1S/C21H25N7O/c1-3-19(15-4-5-15)27-12-17(9-24-27)21-20-6-7-22-28(20)13-18(25-21)16-8-23-26(11-16)10-14(2)29/h6-9,11-15,19,29H,3-5,10H2,1-2H3/t14-,19?/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
ARRAY BIOPHARMA INC.; CELGENE CORPORATION US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US11028093 (2021) BindingDB Entry DOI: 10.7270/Q2T156RN
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK1 (Homo sapiens (Human))	BDBM455552 ((S)-1-(4-(4-(1-((R)-1-cyclopropylpropyl)-1H-pyrazo...) Show SMILES CCC(C1CC1)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](C)O)c1 |r| Show InChI InChI=1S/C21H25N7O/c1-3-19(15-4-5-15)27-12-17(9-24-27)21-20-6-7-22-28(20)13-18(25-21)16-8-23-26(11-16)10-14(2)29/h6-9,11-15,19,29H,3-5,10H2,1-2H3/t14-,19?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	550	n/a	n/a	n/a	n/a	n/a	n/a
ARRAY BIOPHARMA INC.; CELGENE CORPORATION US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US11028093 (2021) BindingDB Entry DOI: 10.7270/Q2T156RN
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM455552 ((S)-1-(4-(4-(1-((R)-1-cyclopropylpropyl)-1H-pyrazo...) Show SMILES CCC(C1CC1)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](C)O)c1 |r| Show InChI InChI=1S/C21H25N7O/c1-3-19(15-4-5-15)27-12-17(9-24-27)21-20-6-7-22-28(20)13-18(25-21)16-8-23-26(11-16)10-14(2)29/h6-9,11-15,19,29H,3-5,10H2,1-2H3/t14-,19?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
ARRAY BIOPHARMA INC.; CELGENE CORPORATION US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US11028093 (2021) BindingDB Entry DOI: 10.7270/Q2T156RN
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK3 (Homo sapiens (Human))	BDBM455552 ((S)-1-(4-(4-(1-((R)-1-cyclopropylpropyl)-1H-pyrazo...) Show SMILES CCC(C1CC1)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(C[C@H](C)O)c1 |r| Show InChI InChI=1S/C21H25N7O/c1-3-19(15-4-5-15)27-12-17(9-24-27)21-20-6-7-22-28(20)13-18(25-21)16-8-23-26(11-16)10-14(2)29/h6-9,11-15,19,29H,3-5,10H2,1-2H3/t14-,19?/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
Array BioPharma Inc.; Celgene Corporation US Patent					Assay Description Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...				US Patent US10730880 (2020) BindingDB Entry DOI: 10.7270/Q2CC13R9
					More data for this Ligand-Target Pair